TDG Form 4: 518 options vest 20% yearly from Sep 30, 2026
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
TransDigm Group (TDG) filed a Form 4 showing a director stock option grant. On 11/04/2025, a reporting person serving as a Director received stock options covering 518 shares at an exercise price of $1,291.97 per share. The options were reported as acquired (Code A) and are held directly.
The options expire on 11/04/2035 and vest at 20% per year over five years beginning September 30, 2026, subject to the achievement of annual operating performance targets in each year.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Santana Michele
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 518 | $0.00 | -- |
Holdings After Transaction:
Stock Option — 518 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did TransDigm (TDG) disclose in this Form 4?
A Director received a grant of stock options covering 518 shares at an exercise price of $1,291.97 per share on 11/04/2025.
What is the vesting schedule for the TDG stock options?
They vest at 20% per year over five years, beginning on September 30, 2026, subject to annual operating performance targets.
When do the TransDigm stock options expire?
The options expire on 11/04/2035.
How were the options reported in terms of ownership?
They were reported as held Direct (D).
What transaction code appears on the Form 4 for this grant?
Transaction Code A, indicating an acquisition (grant) of derivative securities.
What class of securities underlies the options?
The options are exercisable into Common Stock, covering 518 shares.